Pharmaceutics, Volume 16, Issue 7 (July 2024) – 129 articles
Cover Story (view full-size image):
Among all the human barriers, the blood–brain barrier (BBB) maintains the physiological homeostasis of the brain. BBB’s continuous non-fenestrated capillaries system allows precise homeostasis regulation and protection. From a pharmaceutical point of view, it notably complicates the treatment of brain disorders since it impairs chemical drug and biopharmaceutical delivery into the brain reducing their therapeutic efficacy and/or increasing their unwanted bioaccumulation in the surrounding healthy tissues. Nanotechnological innovations provide advanced biomaterials and customized engineering and functionalization methods for brain-targeted drug delivery. Lipid nanocarriers, both synthetic and cell-derived ones, are considered effective brain delivery systems due to their reasonable biocompatibility and ability to cross the BBB.View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Previous Issue
Next Issue
